HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $820 | +9.2% | 21,477 | +3.1% | 0.00% | 0.0% |
Q2 2023 | $751 | -14.5% | 20,823 | -9.4% | 0.00% | 0.0% |
Q1 2023 | $878 | -36.2% | 22,983 | -4.9% | 0.00% | -50.0% |
Q4 2022 | $1,376 | -99.9% | 24,177 | -2.8% | 0.00% | +33.3% |
Q3 2022 | $983,000 | -27.9% | 24,868 | -19.8% | 0.00% | -25.0% |
Q2 2022 | $1,364,000 | -0.7% | 30,992 | -10.0% | 0.00% | +33.3% |
Q1 2022 | $1,374,000 | +9060.0% | 34,441 | +2100.7% | 0.00% | – |
Q4 2016 | $15,000 | +50.0% | 1,565 | +97.6% | 0.00% | – |
Q3 2016 | $10,000 | +11.1% | 792 | -21.4% | 0.00% | – |
Q2 2016 | $9,000 | 0.0% | 1,008 | +10.6% | 0.00% | – |
Q1 2016 | $9,000 | – | 911 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |